Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 8976 - 9000 of 9148 in total

ARGX-119

ARGX-119 is a monoclonal antibody that targets and activates muscle-specific kinase (MuSK).
Investigational

SGN-1

SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational

Briquilimab

Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).
Investigational

Alidornase alfa

Investigational

Atesidorsen

Investigational

Nemvaleukin alfa

Investigational

CLBS12

CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational

SER-287

SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.
Investigational

Eneboparatide

Investigational

NX-210c

Investigational

Gresonitamab

Investigational

Vepsitamab

Investigational

Ifinatamab deruxtecan

Investigational

Haptoglobulin 1/1 (Plasma Derived)

Investigational

KB407

Investigational

Belcesiran

Investigational

SPK-7001

Investigational

M012

Investigational

Nadunolimab

Investigational

OAV401

Investigational

ET-101

Investigational

DR-01

DR-01 is a monoclonal antibody directed against human CD94.
Investigational

MRT5005

MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).
Investigational

C134

C134 is a genetically engineered oncolytic herpes simplex virus expressing human cytomegalovirus (HCMV) internal repeat short 1 (IRS1).
Investigational

TBX-1400

TBX-1400 consists of human donor hematopoietic stem and progenitor cells.
Investigational
Displaying drugs 8976 - 9000 of 9148 in total